1. Home
  2. NMTC vs MYO Comparison

NMTC vs MYO Comparison

Compare NMTC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.78

Market Cap

42.6M

Sector

Health Care

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.70

Market Cap

36.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
MYO
Founded
2009
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
36.9M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
NMTC
MYO
Price
$0.78
$0.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$1.98
$7.67
AVG Volume (30 Days)
221.2K
416.3K
Earning Date
01-01-0001
06-09-2026
Dividend Yield
N/A
N/A
EPS Growth
80.43
N/A
EPS
N/A
N/A
Revenue
$9,097,692.00
$1,000,000,000.00
Revenue This Year
N/A
$15.92
Revenue Next Year
$31.17
$21.49
P/E Ratio
N/A
N/A
Revenue Growth
163.47
40814.79
52 Week Low
$0.40
$0.64
52 Week High
$1.15
$5.62

Technical Indicators

Market Signals
Indicator
NMTC
MYO
Relative Strength Index (RSI) 51.45 39.32
Support Level $0.69 $0.68
Resistance Level $0.89 $1.03
Average True Range (ATR) 0.06 0.07
MACD 0.01 -0.00
Stochastic Oscillator 53.58 23.57

Price Performance

Historical Comparison
NMTC
MYO

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: